- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07309406
Effect of a Nurse-Led Environmental Stressor Reduction Package on Perceived Stress and Sleep Quality in Intensive Care Unit Patients (ICU-SLEEP)
Evaluating the Effects of a Nurse-Led Multicomponent Environmental Intervention on Stress Perception and Sleep Quality in ICU Patients: A Quasi-Experimental Study
This study aims to evaluate the effectiveness of a nurse-led "Environmental Stressor Reduction Package" on critically ill patients' perception of environmental stress and their sleep quality in the intensive care unit (ICU).
The package includes multi-component interventions such as reducing noise levels, adjusting lighting according to circadian rhythm, maintaining thermal comfort, limiting visitor traffic at night, and organizing nursing care to minimize sleep disruption. A structured "Quiet Night Checklist" will be used to monitor the implementation of these interventions during night shifts.
The study will be conducted in the 10-bed anesthesia and reanimation intensive care unit of Ümraniye Training and Research Hospital, İstanbul. Eligible adult patients who are awake, not under sedation, and able to communicate will be recruited. Participants in the intervention group will receive the Environmental Stressor Reduction Package for at least two and up to five consecutive nights, while the control group will continue to receive standard ICU care.
Outcomes will be measured using two validated tools:
The Intensive Care Unit Environmental Stressor Scale (ICUESS) to assess perceived environmental stress.
The Richards-Campbell Sleep Questionnaire (RCSQ) to evaluate self-reported sleep quality.
The findings of this study are expected to contribute to evidence-based nursing interventions in the ICU setting, by improving patients' sleep quality and reducing stressors associated with the intensive care environment.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This semi-experimental study is designed to investigate the effect of a nurse-led "Environmental Stressor Reduction Package" on patients' perception of environmental stress and their sleep quality in the intensive care unit (ICU).
The intervention package includes five core components:
Noise control: Environmental sound levels will be maintained at ≤45 dB during night hours using a portable sound level meter (Benetech GM1351). Non-critical alarms will be silenced or reduced by 50%, and staff will be reminded to minimize unnecessary conversations at the bedside.
Lighting adjustment: Circadian rhythm-oriented lighting will be supported by turning off unnecessary bedside lights during sleep periods, using curtains to block external light, and providing patients with eye masks when needed.
Thermal comfort: As central air conditioning cannot be individually adjusted, tympanic temperature will be monitored and blankets or portable warmers will be used to ensure comfort.
Visitor regulation: No visitors will be allowed after 22:00, and physicians' or staff communications will be conducted as quietly as possible during patients' rest periods.
Nursing care organization: Routine nursing interventions such as hygiene care or repositioning will be scheduled before 22:00 whenever feasible, to minimize sleep interruption between 22:00 and 06:00.
The structured "Quiet Night Checklist" developed by the research team will be used to monitor the fidelity of the intervention. The checklist will be completed at 22:00, 02:00, and 06:00, covering all intervention domains. Each item is scored on a 3-point Likert scale (1 = not implemented, 2 = partially implemented, 3 = fully implemented).
Data collection will be carried out over a minimum of two and up to five consecutive nights of ICU stay, depending on patients' clinical course. The intervention group will receive the package, while the control group will continue to receive standard ICU care.
The primary outcome will be the change in patients' perceived environmental stress, measured by the Intensive Care Unit Environmental Stressor Scale (ICUESS), a validated 42-item instrument. The secondary outcome will be self-reported sleep quality, measured by the Richards-Campbell Sleep Questionnaire (RCSQ), a validated 5-item visual analogue scale. Both instruments have validated Turkish versions (Toptas et al., 2018; Demir et al., 2021).
It is anticipated that the intervention will reduce patients' stress perception and improve sleep quality compared to standard care. The findings will contribute to evidence-based nursing practices in ICU environments, highlighting the role of structured, nurse-led environmental modifications in improving patient outcomes.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: öznur BALKAN, Research Assistant
- Phone Number: +905075803533
- Email: oznur.balkan34@gmail.com
Study Contact Backup
- Name: ADNAN AYDENİZZ
- Phone Number: 05379810926
- Email: adnan.aydeniz@hotmail.com
Study Locations
-
-
Umraniye
-
Istanbul, Umraniye, Turkey (Türkiye), 34000
- Umraniye Education and Research Hospital
-
Contact:
- öznur AYDENİZ
- Phone Number: 05075803533
- Email: adnan.aydeniz@hotmail.com
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 18 years and older
Patients admitted to the intensive care unit (ICU)
Awake and able to communicate (not under sedation or mechanical ventilation)
Expected to remain in the ICU for at least 2 consecutive nights
Voluntary participation with written informed consent
Exclusion Criteria:
- Patients under 18 years old
Patients diagnosed with delirium or severe cognitive impairment
Patients with a history of psychiatric illness affecting sleep or stress perception
Patients under continuous sedative or opioid infusion
Patients discharged from the ICU or deceased before completing the intervention period (2-5 nights)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Quiet Night Protocol (Environmental Stressor Reduction Package)
This arm will receive the Environmental Stressor Reduction Package, a multi-component nursing intervention designed to reduce environmental stressors in the ICU. The package includes: Noise control (≤45 dB, alarms adjusted, staff reminders) Circadian lighting adjustments (bedside lights off during sleep hours, local lighting for procedures, use of eye masks when appropriate) Thermal comfort monitoring (timpanically measured, blankets or controlled bedside warmers if needed) Restricted visitor traffic (no visitors after 22:00, quiet medical rounds at night) Adjustment of care activities (minimizing unnecessary night interventions, clustering nursing care before 22:00) Use of the "Quiet Night Checklist" by nurses at 22:00, 02:00, and 06:00 to standardize monitoring. |
A structured, nurse-led protocol implemented in the ICU to reduce environmental stressors that negatively affect patients' sleep quality.
It combines noise reduction, circadian lighting adjustment, thermal comfort, visitor traffic regulation, and adjustment of care activities.
Nurses use a standardized checklist ("Quiet Night Checklist") at three time points (22:00, 02:00, and 06:00) to ensure consistency and adherence.
|
|
No Intervention: Standard ICU Care
This arm will receive routine ICU care without the structured Environmental Stressor Reduction Package.
Standard care includes typical ICU monitoring, treatments, and nursing interventions according to hospital policies, without specific modifications for noise, light, thermal comfort, or visitor regulation beyond institutional standards.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in environmental stress perception
Time Frame: Baseline and Day 5
|
Environmental stress perception will be assessed using the Intensive Care Unit Environmental Stressor Scale (ICUESS), Turkish validated version (Toptaş, Yıldız, & Khorshid, 2018).
The ICUESS consists of 42 items rated on a 4-point Likert scale ranging from 0 (not stressful) to 3 (very stressful), yielding a total score range of 0 to 126.
Higher total scores indicate greater perceived environmental stress.
|
Baseline and Day 5
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in sleep quality
Time Frame: Baseline and Day 5
|
Sleep quality will be assessed using the Richards-Campbell Sleep Questionnaire (RCSQ), Turkish validated version (Demir, Zaybak, & Erdoğan, 2021).
The RCSQ consists of 5 items rated on a visual analog scale ranging from 0 to 100 mm.
The total score is calculated as the mean of the five items, yielding a score range of 0 to 100.
Higher scores indicate better subjective sleep quality.
|
Baseline and Day 5
|
|
Correlation between environmental stress perception and sleep quality
Time Frame: Day 5 (end of intervention)
|
The association between ICUESS total scores and RCSQ mean scores will be analyzed to determine the relationship between perceived environmental stressors and subjective sleep quality.
|
Day 5 (end of intervention)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention adherence (implementation fidelity)
Time Frame: Nightly, at 22:00, 02:00, and 06:00 during intervention nights (2-5 nights).
|
Adherence to the Quiet Night Protocol will be evaluated using the Sessiz Gece Kontrol Listesi (Quiet Night Control Checklist), developed by the research team.
Items are scored with a 3-point Likert scale (1 = not applied, 2 = partially applied, 3 = fully applied).
Higher total scores indicate higher fidelity of protocol implementation.
|
Nightly, at 22:00, 02:00, and 06:00 during intervention nights (2-5 nights).
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- FenerbahceU-ICUREST-2025
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
What data will be shared? Anonymized individual participant data (IPD) including demographic information (age, sex, diagnosis, length of ICU stay) and primary outcome measures (ICUESS scores and RCSQ scores). No identifying information (e.g., names, contact details, medical record numbers) will be shared.
When will data be available? De-identified data will be available beginning 6 months after publication of the main study results and will remain accessible for 2 years.
With whom and under what conditions? Data will be shared with academic researchers upon submission of a methodologically sound proposal and approval from an institutional review board (IRB) or ethics committee. Interested researchers must sign a data-sharing agreement to ensure confidentiality and appropriate use of data.
How will data be shared? Data will be provided through secure, password-protected institutional servers. Requests can be directed to the principal investigator via email.
IPD Sharing Time Frame
IPD Sharing Access Criteria
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep Disturbance
-
Università degli Studi di BresciaCompletedSleep Phase Rhythm DisturbanceItaly
-
The First Affiliated Hospital of Xiamen UniversityNot yet recruitingPostoperative Sleep Disturbance
-
Our Lady's Hospice and Care ServicesSt Vincent's University Hospital, IrelandEnrolling by invitation
-
Zhuan ZhangNot yet recruitingCircadian Rhythm | Postoperative Sleep DisturbanceChina
-
Riphah International UniversityCompletedSleep Disturbance in AthletesPakistan
-
University of BergenGlamoxCompletedSleep | Sleep Deprivation | Shift-Work Related Sleep DisturbanceNorway
-
Sam Houston State UniversityThe University of Texas Health Science Center, Houston; Memorial Hermann Texas...CompletedSleep Disturbance in Hospitalized Antepartum PatientsUnited States
-
Pacific UniversityCompletedInsomnia | Shift-Work Related Sleep DisturbanceUnited States
-
Seoul National University HospitalNot yet recruiting
-
University of North Carolina, Chapel HillWinclove Probiotics B.V.; National Strength and Conditioning Association FoundationCompletedHealthy | Shift-Work Related Sleep DisturbanceUnited States
Clinical Trials on Environmental Stressor Reduction Package
-
The George Institute for Global Health, ChinaNational Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular DiseaseChina
-
University of BirminghamEuropean Commission; Dudley NHS Foundation TrustCompletedOsteoarthritis | Physical Activity | Sedentary Lifestyle | Orthopedic Disorder | Arthropathy of Knee | Arthropathy of HipUnited Kingdom
-
Brown UniversityNational Cancer Institute (NCI); University of ConnecticutCompletedDietary Habits | Dietary Modification
-
McMaster UniversityNot yet recruiting
-
Shaukat Khanum Memorial Cancer Hospital & Research...Enrolling by invitationAnxiety | Preoperative Anxiety | Patient SatisfactionPakistan
-
National Institute of Allergy and Infectious Diseases...Gilead SciencesCompletedHIV InfectionsMalawi, Zimbabwe, South Africa, Uganda